{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:50:52Z","timestamp":1790812252002,"version":"4.1.0"},"reference-count":252,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>To date, more than 400 types of human papillomavirus (HPV) have been identified. Despite the creation of effective prophylactic vaccines against the most common genital HPVs, the viruses remain among the most prevalent pathogens found in humans. According to WHO data, they are the cause of 5% of all cancers. Even more frequent are persistent and recurrent benign lesions such as genital and common warts. HPVs are resistant to many disinfectants and relatively unsusceptible to external conditions. There is still no drug available to inhibit viral replication, and treatment is based on removing lesions or stimulating the host immune system. This paper presents the systematics of HPV and the differences in HPV structure between different genetic types, lineages, and sublineages, based on the literature and GenBank data. We also present the pathogenesis of diseases caused by HPV, with a special focus on the role played by E6, E7, and other viral proteins in the development of benign and cancerous lesions. We discuss further prospects for the treatment of HPV infections, including, among others, substances that block the entry of HPV into cells, inhibitors of viral early proteins, and some substances of plant origin that inhibit viral replication, as well as new possibilities for therapeutic vaccines.<\/jats:p>","DOI":"10.3390\/ijms25147616","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T08:47:41Z","timestamp":1720774061000},"page":"7616","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["HPV Infections\u2014Classification, Pathogenesis, and Potential New Therapies"],"prefix":"10.3390","volume":"25","author":[{"given":"Beata","family":"Mlynarczyk-Bonikowska","sequence":"first","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Rudnicka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"key":"ref_1","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., G\u00f3mez, D., Mu\u00f1oz, J., Bosch, F.X., de Sanjos\u00e9, S., and ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre) (Summary Report, 2023). Human Papillomavirus and Related Diseases in the World, Summary Report."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex. Transm. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kombe, A.J., Li, B., Zahid, A., Mengist, H.M., Bounda, G.A., Zhou, Y., and Jin, T. (2021). Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front. Public Health, 8.","DOI":"10.3389\/fpubh.2020.552028"},{"key":"ref_4","unstructured":"(2024, April 19). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-papilloma-virus-and-cancer."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/j.lpm.2014.10.001","article-title":"HPV in genital cancers (at the exception of cervical cancer) and anal cancers","volume":"43","author":"Bruni","year":"2014","journal-title":"Presse Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2016.03.016","article-title":"Gardasil-9: A global survey of projected efficacy","volume":"130","author":"Zhai","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_7","first-page":"S7","article-title":"The history of papillomavirus research","volume":"16","year":"2008","journal-title":"Cent. Eur. J. Public Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers\u2014A brief historical account","volume":"384","year":"2009","journal-title":"Virology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Bosch","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e489s","DOI":"10.6061\/clinics\/2018\/e489s","article-title":"Epidemiology and biology of cutaneous human papillomavirus","volume":"73","author":"Nunes","year":"2018","journal-title":"Clinics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virol.2021.03.002","article-title":"Misclassifications in human papillomavirus databases","volume":"558","author":"Eklund","year":"2021","journal-title":"Virology"},{"key":"ref_12","unstructured":"(2024, January 29). International Committee on Taxonomy of Viruses; Book: Papillomaviridae 2024. Available online: https:\/\/ictv.global\/report\/chapter\/papillomaviridae\/papillomaviridae."},{"key":"ref_13","unstructured":"(2024, January 28). Taxonomy Browser (Human Papillomavirus), Available online: https:\/\/www.ncbi.nlm.nih.gov\/Taxonomy\/Browser\/wwwtax.cgi?mode=Undef&name=Viruses&lvl=3&srchmode=1&keep=1&unlock."},{"key":"ref_14","unstructured":"(2024, January 28). International Human Papillomavirus Reference Center. Available online: https:\/\/www.hpvcenter.se."},{"key":"ref_15","unstructured":"(2024, January 29). The Papillomavirus Episteme PaVE, Available online: https:\/\/pave.niaid.nih.gov\/."},{"key":"ref_16","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012 (2012). Biological agents. Volume 100 B. A review of human carcinogens. IARC monographs on the evaluation of carcinogenic risks to humans\/World Health Organization. Int. Agency Res. Cancer, 100, 1\u2013441."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.virol.2016.03.027","article-title":"Identification of novel human papillomavirus lineages and sublineages in HIV\/HPVcoinfected pregnant women by next-generation sequencing","volume":"493","author":"Siqueira","year":"2016","journal-title":"Virology"},{"key":"ref_18","first-page":"13","article-title":"Primer-directed sequencing of human papillomavirus types","volume":"186","author":"Delius","year":"1994","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0042-6822(92)90091-3","article-title":"Human papillomavirus type 42: New sequences, conserved genome organization","volume":"186","author":"Philipp","year":"1992","journal-title":"Virology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/viro.1997.8943","article-title":"The genomes of three of four novel HPV types, defined by differences of their L1 genes, show high conservation of the E7 gene and the URR","volume":"240","author":"Delius","year":"1998","journal-title":"Virology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<356::AID-IJC9>3.0.CO;2-Z","article-title":"Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients","volume":"73","author":"Lavergne","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.virol.2009.12.023","article-title":"Genomic characterization of a novel human papillomavirus (HPV117) with a high viral load in a persisting wart","volume":"399","author":"Kohler","year":"2010","journal-title":"Virology"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kovanda, A., Kocjan, B.J., Potocnik, M., and Poljak, M. (2011). Characterization of a novel cutaneous human papillomavirus genotype HPV125. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022414"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mitsuishi, T., Ohsawa, I., Kato, T., Egawa, N., and Kiyono, T. (2013). Molecular cloning and characterisation of a novel type of human papillomavirus 160 isolated from a flat wart of an immunocompetent patient. PLoS ONE, 8, Erratum in PLoS ONE 2013, 8.","DOI":"10.1371\/annotation\/effe849b-a0a8-4713-b1b0-96759ecafa65"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1006\/bbrc.1994.2533","article-title":"Analysis of short novel human papillomavirus sequences","volume":"204","author":"Tachezy","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","article-title":"Human papillomavirus genome variants","volume":"445","author":"Burk","year":"2013","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/423855","article-title":"Codetection of a mixed population of candHPV62 containing wild-type and disrupted E1 open-reading frame in a 45-year-old woman with normal cytology","volume":"190","author":"Fu","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/viro.2000.0716","article-title":"Complete nucleotide sequence and analysis of a novel human papillomavirus (HPV 84) genome cloned by an overlapping PCR method","volume":"279","author":"Terai","year":"2001","journal-title":"Virology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1086\/340824","article-title":"Identification and characterization of 3 novel genital human papillomaviruses by overlapping polymerase chain reaction: candHPV89, candHPV90, and candHPV91","volume":"185","author":"Terai","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/viro.2001.0865","article-title":"Relationships between 80 human papillomavirus genotypes and different grades of cervical intraepithelial neoplasia: Association and causality","volume":"283","author":"Matsukura","year":"2001","journal-title":"Virology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11913","DOI":"10.1128\/JVI.75.23.11913-11919.2001","article-title":"Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87","volume":"75","author":"Menzo","year":"2001","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/viro.1999.9822","article-title":"Nucleotide sequence and characterization of human papillomavirus type 83, a novel genital papillomavirus","volume":"260","author":"Brown","year":"1999","journal-title":"Virology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2009.11.027","article-title":"Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples","volume":"397","author":"Ekstrom","year":"2010","journal-title":"Virology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0168-1702(90)90091-O","article-title":"A comparative sequence analysis of two human papillomavirus (HPV) types 2a and 57","volume":"18","author":"Delius","year":"1990","journal-title":"Virus Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/viro.1994.1307","article-title":"Human papillomavirus type 2c is identical to human papillomavirus type 27","volume":"201","author":"Chan","year":"1994","journal-title":"Virology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jmv.20422","article-title":"Candidate human papillomavirus (HPV) type 27b: Nucleotide sequence and heterogeneity with HPV 27","volume":"77","author":"Yamaguchi","year":"2005","journal-title":"J. Med. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1128\/jvi.65.8.4216-4225.1991","article-title":"Biologic properties and nucleotide sequence analysis of human papillomavirus type 51","volume":"65","author":"Lungu","year":"1991","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1128\/CDLI.7.1.91-95.2000","article-title":"Molecular cloning and nucleotide sequence analysis of a novel human papillomavirus (type 82) associated with vaginal intraepithelial neoplasia","volume":"7","author":"Kino","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15503","DOI":"10.1128\/JVI.79.24.15503-15510.2005","article-title":"Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses","volume":"79","author":"Narechania","year":"2005","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12250-010-3078-4","article-title":"Detection of HPV types and neutralizing antibodies in women with genital warts in Tianjin City, China","volume":"25","author":"Wu","year":"2010","journal-title":"Virol. Sin."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1128\/jcm.29.11.2656-2660.1991","article-title":"Characterization of human papillomavirus type 66 from an invasive carcinoma of the uterine cervix","volume":"29","author":"Tawheed","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0022-2836(87)90343-3","article-title":"Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products","volume":"193","author":"Cole","year":"1987","journal-title":"J. Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Bello, J.O., Carrillo-Garc\u00eda, A., and Lizano, M. (2022). Epidemiology and molecular biology of HPV variants in cervical cancer: The state of the art in Mexico. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158566"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1128\/JVI.02068-08","article-title":"Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97","volume":"83","author":"Chen","year":"2009","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.22632","article-title":"Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45","volume":"121","author":"Chen","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Chen, Z., Schiffman, M., Herrero, R., Desalle, R., Anastos, K., Segondy, M., Sahasrabuddhe, V.V., Gravitt, P.E., Hsing, A.W., and Burk, R.D. (2013). Evolution and taxonomic classification of Alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072565"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000274977","article-title":"Whole-genome sequence analysis of human papillomavirus type 18 from infected thai women","volume":"53","author":"Lurchachaiwong","year":"2010","journal-title":"Intervirology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0042-6822(91)90518-G","article-title":"Genome organization and nucleotide sequence of human papillomavirus type 39","volume":"181","author":"Volpers","year":"1991","journal-title":"Virology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/viro.1994.1467","article-title":"Nucleotide sequence and phylogenetic classification of human papillomavirus type 59","volume":"203","author":"Rho","year":"1994","journal-title":"Virology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/jcm.34.3.738-744.1996","article-title":"Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39","volume":"34","author":"Longuet","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/jcm.34.4.802-809.1996","article-title":"Human papillomavirus type 70 genome cloned from overlapping PCR products: Complete nucleotide sequence and genomic organization","volume":"34","author":"Forslund","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1099\/0022-1317-80-11-2923","article-title":"Complete nucleotide sequence, genomic organization and phylogenetic analysis of a novel genital human papillomavirus type, HLT7474-S","volume":"80","author":"Chow","year":"1999","journal-title":"J. Gen. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Burk, R.D., Mirabello, L., and DeSalle, R. (2023). Distinguishing genetic drift from selection in papillomavirus evolution. Viruses, 15.","DOI":"10.3390\/v15081631"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Guerendiain, D., M\u00fchr, L.S.A., Grigorescu, R., Holden, M.T.G., and Cuschieri, K. (2022). Mapping HPV 16 sub-lineages in anal cancer and implications for disease outcomes. Diagnostics, 12.","DOI":"10.3390\/diagnostics12123222"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Mirabello, L., Clarke, M.A., Nelson, C.W., Dean, M., Wentzensen, N., Yeager, M., Cullen, M., Boland, J.F., NCI HPV Workshop, and Schiffman, M. (2018). The intersection of HPV epidemiology, genomics and mechanistic studies of HPV mediated carcinogenesis. Viruses, 10.","DOI":"10.3390\/v10020080"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pvr.2019.02.001","article-title":"Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women","volume":"7","author":"Clifford","year":"2019","journal-title":"Papillomavirus Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12935-023-03011-8","article-title":"Type distribution of human papillomaviruses in ThinPrep cytology samples and HPV16\/18 E6 gene variations in FFPE cervical cancer specimens in Fars province, Iran","volume":"23","author":"Farhadi","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0042-6822(85)90214-4","article-title":"Human papillomavirus type 16 DNA sequence","volume":"145","author":"Seedorf","year":"1985","journal-title":"Virology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/jvi.65.4.2093-2097.1991","article-title":"A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability","volume":"65","author":"Kennedy","year":"1991","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Smith, B., Chen, Z., Reimers, L., van Doorslaer, K., Schiffman, M., Desalle, R., Herrero, R., Yu, K., Wacholder, S., and Wang, T. (2011). Sequence imputation of HPV16 genomes for genetic association studies. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021375"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1128\/JVI.79.11.7014-7023.2005","article-title":"Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Chen, Z., Schiffman, M., Herrero, R., Desalle, R., Anastos, K., Segondy, M., Sahasrabuddhe, V.V., Gravitt, P.E., Hsing, A.W., and Burk, R.D. (2011). Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020183"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Pinheiro, M., Harari, A., Schiffman, M., Clifford, G.M., Chen, Z., Yeager, M., Cullen, M., Boland, J.F., Raine-Bennett, T., and Steinberg, M. (2021). Phylogenomic analysis of human Papillomavirus type 31 and cervical carcinogenesis: A study of 2093 viral genomes. Viruses, 13.","DOI":"10.3390\/v13101948"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0042-6822(89)90545-X","article-title":"Nucleotide sequence of human papillomavirus type 31: A cervical neoplasia-associated virus","volume":"171","author":"Goldsborough","year":"1989","journal-title":"Virology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/jvi.58.3.991-995.1986","article-title":"Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer","volume":"58","author":"Cole","year":"1986","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jmv.21435","article-title":"Detection of HPV types and neutralizing antibodies in Gansu province, China","volume":"81","author":"Wu","year":"2009","journal-title":"J. Med. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0042-6822(91)90791-9","article-title":"Human papillomavirus type 58 DNA sequence","volume":"185","author":"Kirii","year":"1991","journal-title":"Virology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1008002905588","article-title":"Nucleotide sequence and phylogenetic classification of human papillomavirus type 67","volume":"17","author":"Kirii","year":"1998","journal-title":"Virus Genes"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Bee, K.J., Gradissimo, A., Chen, Z., Harari, A., Schiffman, M., Raine-Bennett, T., Castle, P.E., Clarke, M., Wentzensen, N., and Burk, R.D. (2021). Genetic and epigenetic variations of HPV52 in cervical precancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126463"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Danielewski, J.A., Garland, S.M., McCloskey, J., Hillman, R.J., and Tabrizi, S.N. (2013). Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia. PLoS ONE, 8, Erratum in: PLoS ONE 2015, 10, e0117962.","DOI":"10.1371\/journal.pone.0117962"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1002\/j.1460-2075.1983.tb01744.x","article-title":"DNA sequence and genome organization of genital human papillomavirus type 6b","volume":"2","author":"Schwarz","year":"1983","journal-title":"EMBO J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1017\/S0950268816000388","article-title":"Determination of the complete genome and functional analysis of HPV6 isolate VBD19\/10 from a patient with aggressive recurrent respiratory papillomatosis","volume":"144","author":"Seedat","year":"2016","journal-title":"Epidemiol. Infect."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1128\/JVI.00621-14","article-title":"Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences","volume":"88","author":"Jelen","year":"2014","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1128\/JVI.03149-15","article-title":"Global genomic diversity of human papillomavirus 11 based on 433 isolates and 78 complete genome sequences","volume":"90","author":"Jelen","year":"2016","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1099\/0022-1317-80-9-2445","article-title":"Human papillomavirus type 6: Classification of clinical isolates and functional analysis of E2 proteins","volume":"80","author":"Kovelman","year":"1999","journal-title":"J. Gen. Virol."},{"key":"ref_76","first-page":"113","article-title":"Classification and nomenclature system for human Alphapapillomavirus variants: General features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages","volume":"20","author":"Burk","year":"2011","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.meegid.2011.06.022","article-title":"Pre-vaccination genomic diversity of human papillomavirus genotype 6 (HPV 6): A comparative analysis of 21 full-length genome sequences","volume":"11","author":"Kocjan","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1006\/viro.1995.1283","article-title":"Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae","volume":"209","author":"Hofmann","year":"1995","journal-title":"Virology"},{"key":"ref_79","first-page":"1305","article-title":"Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: Chromosomal localization and nucleotide sequence of the genomic target region","volume":"54","author":"Kahn","year":"1994","journal-title":"Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00301984","article-title":"Structural analysis of human papillomavirus type 6c isolates from condyloma acuminatum and juvenile-onset and adult-onset laryngeal papillomata","volume":"3","author":"Metcalfe","year":"1989","journal-title":"Virus Genes"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0042-6822(86)90110-8","article-title":"The nucleotide sequence and genome organization of human papilloma virus type 11","volume":"151","author":"Dartmann","year":"1986","journal-title":"Virology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jmv.21994","article-title":"Prevaccination genomic diversity of human papillomavirus genotype 11: A study on 63 clinical isolates and 10 full-length genome sequences","volume":"83","author":"Maver","year":"2011","journal-title":"J. Med. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"104595","DOI":"10.1016\/j.meegid.2020.104595","article-title":"Genomic characterization of human papillomavirus type 13, associated to multifocal epithelial hyperplasia, in a Mayan community","volume":"91","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0042-6822(92)90896-W","article-title":"Human papillomavirus type 13 and pygmy chimpanzee papillomavirus type 1: Comparison of the genome organizations","volume":"190","author":"Fuse","year":"1992","journal-title":"Virology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"baaa062","DOI":"10.1093\/database\/baaa062","article-title":"NCBI Taxonomy: A comprehensive update on curation, resources and tools","volume":"2020","author":"Schoch","year":"2020","journal-title":"Database"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-0215(19960516)66:4<453::AID-IJC7>3.0.CO;2-V","article-title":"Novel HPV types present in oral papillomatous lesions from patients with HIV infection","volume":"66","author":"Volter","year":"1996","journal-title":"Int. J. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0042-6822(87)90263-7","article-title":"Nucleotide sequence and genome organization of human papillomavirus type 5","volume":"158","author":"Zachow","year":"1987","journal-title":"Virology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0042-6822(91)91013-7","article-title":"A subtype of human papillomavirus 5 (HPV5b) and its subgenomic segment amplified in a carcinoma: Nucleotide sequences and genomic organizations","volume":"183","author":"Yabe","year":"1991","journal-title":"Virology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/jvi.58.2.626-634.1986","article-title":"Epidermodysplasia verruciformis-associated human papillomavirus 8: Genomic sequence and comparative analysis","volume":"58","author":"Fuchs","year":"1986","journal-title":"J. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/jvi.52.3.1013-1018.1984","article-title":"Molecular cloning and characterization of the genomes of nine newly recognized human papillomavirus types associated with epidermodysplasia verruciformis","volume":"52","author":"Kremsdorf","year":"1984","journal-title":"J. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0042-6822(86)90464-2","article-title":"Characterization of a new type of human papillomavirus (HPV) related to HPV5 from a case of actinic keratosis","volume":"154","author":"Kawashima","year":"1986","journal-title":"Virology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0042-6822(90)90500-Q","article-title":"Genome organization and taxonomic position of human papillomavirus type 47 inferred from its DNA sequence","volume":"177","author":"Kiyono","year":"1990","journal-title":"Virology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1099\/vir.0.82679-0","article-title":"Characterization of two novel cutaneous human papillomaviruses, HPV93 and HPV96","volume":"88","author":"Vasiljevic","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1099\/vir.0.011478-0","article-title":"Characterization of seven novel human papillomavirus types isolated from cutaneous tissue, but also present in mucosal lesions","volume":"90","author":"Gunst","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/infdis\/jir383","article-title":"The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera","volume":"204","author":"Bottalico","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1523-1747.ep12285630","article-title":"Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: Detection of a new sequence related to epidermodysplasia verruciformis associated types","volume":"108","author":"Hopfl","year":"1997","journal-title":"J. Investig. Dermatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ijc.2910370406","article-title":"Molecular cloning of two new HPV types (HPV 37 and HPV 38) from a keratoacanthoma and a alignant melanoma","volume":"37","author":"Scheurlen","year":"1986","journal-title":"Int. J. Cancer"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4149\/av_2018_208","article-title":"Characterization of a new genotype of Betapapillomavirus HPV 17 through L1, E7, E7 and LCR sequences","volume":"62","author":"Oliveira","year":"2018","journal-title":"Acta Virol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/vir.0.2008\/001925-0","article-title":"Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis","volume":"89","author":"Vasiljevic","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1099\/vir.0.041897-0","article-title":"Characterization of human papillomavirus type 120: A novel betapapillomavirus with tropism for multiple anatomical niches","volume":"93","author":"Bottalico","year":"2012","journal-title":"J. Gen. Virol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.meegid.2004.05.009","article-title":"Distribution of human papillomavirus genotypes in plucked eyebrow hairs from Slovenian males with genital warts Infect","volume":"5","author":"Kocjan","year":"2005","journal-title":"Genet. Evol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Kovanda, A., Kocjan, B.J., Luzar, B., Bravo, I.G., and Poljak, M. (2011). Characterization of novel cutaneous human papillomavirus genotypes HPV150 and HPV151. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0022529"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e00298-13","DOI":"10.1128\/genomeA.00298-13","article-title":"Complete genome sequence of a novel human Betapapillomavirus, HPV159","volume":"1","author":"Kocjan","year":"2013","journal-title":"Genome Announc."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e00445-13","DOI":"10.1128\/genomeA.00445-13","article-title":"Novel human papillomavirus type 174 from a cutaneous squamous cell carcinoma","volume":"1","author":"Kocjan","year":"2013","journal-title":"Genome Announc."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Markovi\u0107, I., Hosnjak, L., Seme, K., and Poljak, M. (2021). Molecular characterization of human papillomavirus type 159 (HPV159). Viruses, 13.","DOI":"10.3390\/v13081668"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e01642-16","DOI":"10.1128\/genomeA.01642-16","article-title":"Complete genome sequence of a novel human Betapapillomavirus isolated from a skin sample","volume":"5","author":"Dutta","year":"2017","journal-title":"Genome Announc."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1099\/jgv.0.000774","article-title":"Natural history of human papillomavirus infection of sun-exposed healthy skin of immunocompetent individuals over three climatic seasons and identification of HPV209, a novel betapapillomavirus","volume":"98","author":"Bolatti","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e01628-18","DOI":"10.1128\/MRA.01628-18","article-title":"Isolation of a novel beta-2 human papillomavirus from skin","volume":"8","author":"Brancaccio","year":"2019","journal-title":"Microbiol. Resour. Announc."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2009.11.020","article-title":"New generic primer system targeting mucosal\/genital and cutaneous human papillomaviruses leads to the characterization of HPV 115, a novel Betapapillomavirus species 3","volume":"397","author":"Chouhy","year":"2010","journal-title":"Virology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0042-6822(03)00391-X","article-title":"Nucleotide sequence and phylogenetic classification of candidate human papilloma virus type 92","volume":"312","author":"Forslund","year":"2003","journal-title":"Virology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/infdis\/jiy632","article-title":"Prevalence and correlates of \u03b2- and \u03b3-human papillomavirus detection in oral samples from mid-adult women","volume":"219","author":"Winer","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1006\/viro.1993.1320","article-title":"Two novel types of human papillomavirus, HPV 63 and HPV 65:comparisons of their clinical and histological features and DNA sequences to other HPV types","volume":"194","author":"Egawa","year":"1993","journal-title":"Virology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jcv.2013.10.028","article-title":"Characterization of three novel human papillomavirus types isolated from oral rinse samples of healthy individuals","volume":"59","author":"Martin","year":"2014","journal-title":"J. Clin. Virol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.meegid.2016.04.018","article-title":"Characterization of novel human papillomavirus types 157, 158 and 205 from healthy skin and recombination analysis in genus gamma-Papillomavirus","volume":"42","author":"Bolatti","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/jvi.63.11.4907-4908.1989","article-title":"Human papillomavirus type 48","volume":"63","author":"Muller","year":"1989","journal-title":"J. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2015.07.023","article-title":"Does human papillomavirus-negative condylomata exist?","volume":"485","author":"Bzhalava","year":"2015","journal-title":"Virology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1128\/jvi.63.11.4910-.1989","article-title":"Human papillomavirus (HPV) type 50, a type associated with epidermodysplasia verruciformis (EV) and only weakly related to other EV-specific HPVs","volume":"63","author":"Favre","year":"1989","journal-title":"J. Virol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0042-6822(92)91254-R","article-title":"Molecular cloning of a novel human papillomavirus (type 60) from a plantar cyst with characteristic pathological changes","volume":"190","author":"Matsukura","year":"1992","journal-title":"Virology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ijc.23115","article-title":"Cutaneous human papillomavirus 88: Remarkable differences in viral load","volume":"122","author":"Kullander","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1128\/JVI.02490-08","article-title":"E7 oncoprotein of novel human papillomavirus type 108 lacking the E6 gene induces dysplasia in organotypic keratinocyte cultures","volume":"83","author":"Nobre","year":"2009","journal-title":"J. Virol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.virol.2006.10.022","article-title":"Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses","volume":"360","author":"Chen","year":"2007","journal-title":"Virology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pvr.2019.02.005","article-title":"Discovery, characterisation and genomic variation of six novel Gammapapillomavirus types from penile swabs in South Africa","volume":"7","author":"Murahwa","year":"2019","journal-title":"Papillomavirus Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"e00114-18","DOI":"10.1128\/genomeA.00114-18","article-title":"Complete genome sequence of a novel human Gammapapillomavirus isolated from a cervical swab in Luxembourg","volume":"6","author":"Latsuzbaia","year":"2018","journal-title":"Genome Announc."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/ijc.26204","article-title":"High throughput sequencing reveals diversity of Human Papillomaviruses in cutaneous lesions","volume":"129","author":"Bzhalava","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1099\/vir.0.030593-0","article-title":"Genomic characterization of ten novel cutaneous human papillomaviruses from keratotic lesions of immunosuppressed patients","volume":"92","author":"Kohler","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"11936","DOI":"10.1128\/JVI.01988-12","article-title":"Nine complete genome sequences of cutaneous human papillomavirus genotypes isolated from healthy skin of individuals living in rural he nan province, China","volume":"86","author":"Li","year":"2012","journal-title":"J. Virol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e29019","DOI":"10.1002\/jmv.29019","article-title":"Prevalence of novel gamma HPV types 223 and 225 in oral cavity and skin of Indian normal and neoplastic participants","volume":"95","author":"Chatterjee","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e77116","DOI":"10.1371\/journal.pone.0077116","article-title":"Identification and characterization of eleven novel human gamma-papillomavirus isolates from healthy skin, found at low frequency in a normal population","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1099\/vir.0.012344-0","article-title":"Identification of a novel human gammapapillomavirus species","volume":"90","author":"Li","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2013.01.023","article-title":"Metagenomic sequencing of \u2018HPVnegative\u2019 condylomas detects novel putative HPV types","volume":"440","author":"Johansson","year":"2013","journal-title":"Virology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e00584-18","DOI":"10.1128\/genomeA.00584-18","article-title":"Complete genome sequences of four novel human Gammapapillomavirus types, HPV219, HPV220, HPV221, and HPV222, isolated from penile skin swabs from South African men","volume":"6","author":"Murahwa","year":"2018","journal-title":"Genome Announc."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2011.10.011","article-title":"Molecular cloning and characterization of a novel human papillomavirus, HPV 126, isolated from a flat wart-like lesion with intracytoplasmic inclusion bodies and a peculiar distribution of Ki-67 and p53","volume":"422","author":"Egawa","year":"2012","journal-title":"Virology"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Ure, A.E., and Forslund, O. (2014). Characterization of human papillomavirus type 154 and tissue tropism of Gammapapillomaviruses. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089342"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chom.2010.05.006","article-title":"Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin","volume":"7","author":"Schowalter","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Ostrbenk, A., Kocjan, B.J., Hosnjak, L., Li, J., Deng, Q., Sterbenc, A., and Poljak, M. (2015). Identification of a novel human papillomavirus, type HPV199, isolated from a nasopharynx and anal canal, and complete genomic characterization of papillomavirus species Gamma-12. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138628"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.virol.2018.09.006","article-title":"High prevalence of Gammapapillomaviruses (Gamma-PVs) in pre-malignant cutaneous lesions of immunocompetent individuals using a new broad-spectrum primer system, and identification of HPV210, a novel Gamma-PV type","volume":"525","author":"Bolatti","year":"2018","journal-title":"Virology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/OLQ.0b013e31827aa9b3","article-title":"Human papillomavirus typing in reporting of condyloma","volume":"40","author":"Johansson","year":"2013","journal-title":"Sex. Transm. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Hosnjak, L., Kocjan, B.J., Pir\u0161, B., Seme, K., and Poljak, M. (2015). Characterization of two novel Gammapapillomaviruses, HPV179 and HPV184, isolated from common warts of a renal-transplant recipient. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0119154"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Hosnjak, L., Kocjan, B.J., Pir\u0161, B., Seme, K., and Poljak, M. (2021). The genetic diversity of human papillomavirus types from the species Gammapapillomavirus 15: HPV135, HPV146, and HPV179. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0249829"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1099\/vir.0.048157-0","article-title":"Identification of human papillomavirus type 156, the prototype of a new human gammapapillomavirus species, by a generic and highly sensitive PCR strategy for long DNA fragments","volume":"94","author":"Chouhy","year":"2013","journal-title":"J. Gen. Virol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e00443-14","DOI":"10.1128\/genomeA.00443-14","article-title":"Complete genome sequences of three novel human papillomavirus types, 175, 178, and 180","volume":"2","author":"Johansson","year":"2014","journal-title":"Genome Announc."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/ijc.29325","article-title":"Human papillomavirus type 197 is commonly present in skin tumors","volume":"136","author":"Hultin","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/j.1460-2075.1982.tb01152.x","article-title":"Human papillomavirus 1a complete DNA sequence: A novel type of genome organization among papovaviridae","volume":"1","author":"Danos","year":"1982","journal-title":"EMBO J."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Sterbenc, A., Hosnjak, L., Chouhy, D., Bolatti, E.M., O\u0161trbenk, A., Seme, K., Kocjan, B.J., Luzar, B., Giri, A.A., and Poljak, M. (2017). Molecular characterization, tissue tropism, and genetic variability of the novel Mupapillomavirus type HPV204 and phylogenetically related types HPV1 and HPV63. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175892"},{"key":"ref_146","first-page":"21","article-title":"Genome announcement: Complete genome sequence of a novel Mupapillomavirus, HPV204","volume":"24","author":"Kocjan","year":"2015","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0168-1702(91)90017-P","article-title":"Nucleotide sequence of human papillomavirus (HPV) type 41: An unusual HPV type without a typical E2 binding site consensus sequence","volume":"18","author":"Hirt","year":"1991","journal-title":"Virus Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1128\/JVI.02726-07","article-title":"Arrangement of L2 within the papillomavirus capsid","volume":"82","author":"Buck","year":"2008","journal-title":"J. Virol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.virol.2013.04.017","article-title":"L2, the minor capsid protein of papillomavirus","volume":"445","author":"Wang","year":"2013","journal-title":"Virology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1128\/JVI.77.8.4818-4826.2003","article-title":"Interactions between papillomavirus L1 and L2 capsid proteins","volume":"77","author":"Finnen","year":"2003","journal-title":"J. Virol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2147\/IJN.S269986","article-title":"Peptide-based nanovaccines in the treatment of cervical cancer: A review of recent advances","volume":"17","author":"Zhang","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Radosevich, J.A. (2012). Proteins encoded by the human papillomavirus genome and their functions. HPV and Cancer, Springer.","DOI":"10.1007\/978-94-007-5437-9"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Egawa, N., Shiraz, A., Crawford, R., Saunders-Wood, T., Yarwood, J., Rogers, M., Sharma, A., Eichenbaum, G., and Doorbar, J. (2021). Dynamics of papillomavirus in vivo disease formation & susceptibility to high-level disinfection-implications for transmission in clinical settings. EBioMedicine, 63.","DOI":"10.1016\/j.ebiom.2020.103177"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Meyers, C., Milici, J., and Robison, R. (2017). UVC radiation as an effective disinfectant method to inactivate human papillomaviruses. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0187377"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3892\/etm.2020.9316","article-title":"Non-sexual HPV transmission and role of vaccination for a better future (review)","volume":"20","author":"Petca","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Yu, L., Majerciak, V., and Zheng, Z.M. (2022). HPV16 and HPV18 genome structure, expression, and post-transcriptional regulation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094943"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1042\/CS20160786","article-title":"The human papillomavirus replication cycle, and its links to cancer progression: A comprehensive review","volume":"131","author":"Graham","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrrev.2016.09.004","article-title":"HPV entry into cells","volume":"772","author":"Aksoy","year":"2017","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e2169","DOI":"10.1002\/rmv.2169","article-title":"Regulation of autophagy by high- and low-risk human papillomaviruses","volume":"31","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Cruz, L., and Meyers, C. (2013). Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068379"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Mikuli\u010di\u0107, S., Strunk, J., and Florin, L. (2021). HPV16 entry into epithelial cells: Running a gauntlet. Viruses, 13.","DOI":"10.3390\/v13122460"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"001540","DOI":"10.1099\/jgv.0.001540","article-title":"The human papillomavirus oncoproteins: A review of the host pathways targeted on the road to transformation","volume":"102","author":"Scarth","year":"2021","journal-title":"J. Gen. Virol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Graham, S.V. (2017). Keratinocyte differentiation-dependent human papillomavirus gene regulation. Viruses, 9.","DOI":"10.3390\/v9090245"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Moody, C. (2017). Mechanisms by which HPV induces a replication competent environment in differentiating keratinocytes. Viruses, 9.","DOI":"10.3390\/v9090261"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Della Fera, A.N., Warburton, A., Coursey, T.L., Khurana, S., and McBride, A.A. (2021). Persistent human papillomavirus infection. Viruses, 13.","DOI":"10.3390\/v13020321"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2010.07.044","article-title":"HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells","volume":"407","author":"Campo","year":"2010","journal-title":"Virology"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Chen, B., Zhao, L., Yang, R., and Xu, T. (2023). Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis. Arch. Biochem. Biophys., 745.","DOI":"10.1016\/j.abb.2023.109716"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2217\/fmb.10.107","article-title":"Human papillomavirus: Gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies","volume":"5","author":"Graham","year":"2010","journal-title":"Future Microbiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature16481","article-title":"Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53","volume":"529","author":"Ruiz","year":"2016","journal-title":"Nature"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: Pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat. Rev. Cancer."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Fu, L., Van Doorslaer, K., Chen, Z., Ristriani, T., Masson, M., Trav\u00e9, G., and Burk, R.D. (2010). Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012816"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1073\/pnas.1819534116","article-title":"PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis","volume":"116","author":"Hatterschide","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4161\/cbt.11.3.14686","article-title":"Molecular pathogenesis of cervical cancer","volume":"11","author":"Ibeanu","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Katzenellenbogen, R. (2017). Telomerase induction in HPV infection and oncogenesis. Viruses, 9.","DOI":"10.3390\/v9070180"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.3390\/v7072785","article-title":"The human papillomavirus E6 PDZ binding motif: From life cycle to malignancy","volume":"7","author":"Ganti","year":"2015","journal-title":"Viruses"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.currproblcancer.2018.03.003","article-title":"HPV: Molecular pathways and targets","volume":"42","author":"Gupta","year":"2018","journal-title":"Curr. Probl. Cancer."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Gheit, T. (2019). Mucosal and cutaneous human papillomavirus Infections and cancer biology. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00355"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1038\/s41388-020-01431-8","article-title":"HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers","volume":"39","author":"Ren","year":"2020","journal-title":"Oncogene"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virusres.2016.11.023","article-title":"Evasion of host immune defenses by human papillomavirus","volume":"231","author":"Westrich","year":"2017","journal-title":"Virus Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/infdis\/jiv753","article-title":"Natural acquired immunity against subsequent genital human papillomavirus infection: A systematic review and meta-analysis","volume":"213","author":"Beachler","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Zhou, C., Tuong, Z.K., and Frazer, I.H. (2019). Papillomavirus immune evasion strategies target the infected cell and the local immune system. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00682"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Tang, J., Li, M., Zhao, C., Shen, D., Liu, L., Zhang, X., and Wei, L. (2022). Therapeutic DNA vaccines against HPV-related malignancies: Promising leads from clinical trials. Viruses, 14.","DOI":"10.3390\/v14020239"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"12850","DOI":"10.1111\/sji.12850","article-title":"Is there a role played by HLA-E, if any, in HPV immune evasion?","volume":"91","author":"Franciosi","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bpobgyn.2017.09.008","article-title":"Therapeutic HPV vaccines","volume":"47","author":"Hancock","year":"2018","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Kamolratanakul, S., and Pitisuttithum, P. (2021). Human papillomavirus vaccine efficacy and effectiveness against cancer. Vaccines, 9.","DOI":"10.3390\/vaccines9121413"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Rochefort, J., Karagiannidis, I., Baillou, C., Belin, L., Guillot-Delost, M., Macedo, R., Le Moignic, A., Mateo, V., Soussan, P., and Brocheriou, I. (2023). Defining biomarkers in oral cancer according to smoking and drinking status. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1068979"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/mc.23188","article-title":"The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses","volume":"59","author":"Westrich","year":"2020","journal-title":"Mol. Carcinog."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Harper, A., Vijayakumar, V., Ouwehand, A.C., Ter Haar, J., Obis, D., Espadaler, J., Binda, S., Desiraju, S., and Day, R. (2021). Viral infections, the microbiome, and probiotics. Front. Cell Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.596166"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5114\/dr.2020.96355","article-title":"Human papillomavirus (HPV) coinfection with other sexually transmitted infections in patients of the Department of Dermatology and Venereology at the Medical University of Warsaw","volume":"107","author":"Bukowska","year":"2020","journal-title":"Dermatol. Rev."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/1471-0528.15854","article-title":"The vaginal microbiota, human papillomavirus and cervical dysplasia: A systematic review and network meta-analysis","volume":"127","author":"Norenhag","year":"2020","journal-title":"BJOG"},{"key":"ref_194","first-page":"191","article-title":"The occurrence of human papillomavirus--HPV in the biopsies from colon polyps and cancer","volume":"61","author":"Mlynarczyk","year":"2009","journal-title":"Med. Dosw. Mikrobiol."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Bristow, I. (2022). Paediatric cutaneous warts and verrucae: An update. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192416400"},{"key":"ref_196","first-page":"165","article-title":"Different skin wart types, different human papillomavirus types? A narrative review","volume":"32","author":"Skubic","year":"2023","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2170662","DOI":"10.1080\/21645515.2023.2170662","article-title":"Epidemiology of human papillomavirus on condyloma acuminatum in Shandong Province, China","volume":"19","author":"Yuan","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Wang, Q., Xu, L., Li, X., Yu, M., and Chen, Q. (2023). Multifocal epithelial hyperplasia confined to the interdental papilla of an adult Chinese man: A rare case report and literature review. BMC Oral Health, 23.","DOI":"10.1186\/s12903-023-03282-7"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Becerril, S., Corchado-Cobos, R., Garc\u00eda-Sancha, N., Revelles, L., Revilla, D., Ugalde, T., Rom\u00e1n-Curto, C., P\u00e9rez-Losada, J., and Ca\u00f1ueto, J. (2021). Viruses and skin cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105399"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/1346-8138.16697","article-title":"Recent advances in cutaneous HPV infection","volume":"50","author":"Shimizu","year":"2023","journal-title":"J. Dermatol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and meta-analysis","volume":"12","author":"Drolet","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/infdis\/jiaa621","article-title":"Human papillomavirus vaccines","volume":"224","author":"Markowitz","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1080\/21645515.2019.1565267","article-title":"Addressing HPV vaccine myths: Practical information for healthcare providers","volume":"15","author":"Bednarczyk","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2308378","DOI":"10.1080\/21645515.2024.2308378","article-title":"High impact of quadrivalent human papillomavirus vaccine across racial\/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018","volume":"20","author":"Stefanos","year":"2024","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Williamson, A.L. (2023). Recent developments in human papillomavirus (HPV) vaccinology. Viruses, 15.","DOI":"10.3390\/v15071440"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Li, M., Zhao, C., Zhao, Y., Li, J., and Wei, L. (2023). Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1112750"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Mo, Y., Ma, J., Zhang, H., Shen, J., Chen, J., Hong, J., Xu, Y., and Qian, C. (2022). Prophylactic and therapeutic HPV vaccines: Current scenario and perspectives. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.909223"},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Huber, B., Wang, J.W., Roden, R.B.S., and Kirnbauer, R. (2021). RG1-VLP and other L2-based, broad-spectrum HPV vaccine candidates. J. Clin. Med., 10.","DOI":"10.3390\/jcm10051044"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2184760","DOI":"10.1080\/21645515.2023.2184760","article-title":"Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials","volume":"19","author":"Goldstone","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13027-023-00547-2","article-title":"Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? review and prospect","volume":"18","author":"Han","year":"2023","journal-title":"Infect. Agent Cancer"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Karimi-Zarchi, M., Allahqoli, L., Nehmati, A., Kashi, A.M., Taghipour-Zahir, S., and Alkatout, I. (2020). Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-8371-z"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"e070135","DOI":"10.1136\/bmj-2022-070135","article-title":"Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: Systematic review and meta-analysis","volume":"378","author":"Kechagias","year":"2022","journal-title":"BMJ"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"101224","DOI":"10.1016\/j.mam.2023.101224","article-title":"Vaccines for HPV-associated diseases","volume":"94","author":"Skolnik","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s40136-023-00443-8","article-title":"Therapeutic vaccination for HPV-mediated cancers","volume":"11","author":"Yan","year":"2023","journal-title":"Curr. Otorhinolaryngol. Rep."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2019.03.250","article-title":"The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up","volume":"153","author":"Harper","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.5306\/wjco.v5.i5.1002","article-title":"Immune therapy for human papillomaviruses-related cancers","volume":"5","author":"Rosales","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/hed.25477","article-title":"MVA E2 therapeutic vaccine for marked reduction in likelihood of recurrence of respiratory papillomatosis","volume":"41","year":"2019","journal-title":"Head Neck"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: A randomised, double-blind, placebo-controlled phase 2b trial","volume":"386","author":"Trimble","year":"2015","journal-title":"Lancet"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1158\/1078-0432.CCR-19-1513","article-title":"A phase II, prospective, randomized, multicenter, open-label study of GX-188E, an HPV DNA vaccine, in patients with cervical intraepithelial neoplasia 3","volume":"26","author":"Choi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/1940-6207.CAPR-22-0413","article-title":"Safety run-in of intramuscular pNGVL4a-Sig\/E7(detox)\/HSP70 DNA and TA-CIN protein vaccination as treatment for HPV16+ ASC-US, ASC-H, or LSIL\/CIN1","volume":"16","author":"Einstein","year":"2023","journal-title":"Cancer Prev. Res."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Ikeda, Y., Adachi, K., Tomio, K., Eguchi-Kojima, S., Tsuruga, T., Uchino-Mori, M., Taguchi, A., Komatsu, A., Nagamatsu, T., and Oda, K. (2021). A placebo-controlled, double-blind randomized (phase IIB) trial of oral administration with HPV16 E7-expressing Lactobacillus, GLBL101c, for the treatment of cervical intraepithelial neoplasia grade 2 (CIN2). Vaccines, 9.","DOI":"10.3390\/vaccines9040329"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"pkad101","DOI":"10.1093\/jncics\/pkad101","article-title":"Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3","volume":"7","author":"Kawana","year":"2023","journal-title":"JNCI Cancer Spectr."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.3802\/jgo.2019.30.e88","article-title":"A phase 1\/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3","volume":"30","author":"Park","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"e005016","DOI":"10.1136\/jitc-2022-005016","article-title":"Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-) malignant lesions","volume":"10","author":"Speetjens","year":"2022","journal-title":"J. Immunother. Cancer."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa0810097","article-title":"Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia","volume":"361","author":"Kenter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Akhatova, A., Chan, C.K., Azizan, A., and Aimagambetova, G. (2021). The efficacy of therapeutic DNA vaccines expressing the human papillomavirus E6 and E7 oncoproteins for treatment of cervical cancer: Systematic review. Vaccines, 10.","DOI":"10.3390\/vaccines10010053"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1078-0432.CCR-22-1987","article-title":"Safety and efficacy of MEDI0457 plus Durvalumab in patients with human papillomavirus-associated recurrent\/metastatic head and neck squamous cell carcinoma","volume":"29","author":"Aggarwal","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/oncolo\/oyad085","article-title":"Phase II trial of MEDI0457 and Durvalumab for patients with recurrent\/metastatic human papillomavirus-associated cancers","volume":"28","author":"Morris","year":"2023","journal-title":"Oncologist"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1080\/21645515.2021.1893036","article-title":"ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer","volume":"17","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"eabn3464","DOI":"10.1126\/scitranslmed.abn3464","article-title":"Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice","volume":"15","author":"Muramatsu","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/jcm4050832","article-title":"Advancements in pharmacotherapy for noncancerous manifestations of HPV","volume":"4","author":"Kollipara","year":"2015","journal-title":"J. Clin. Med."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"F71","DOI":"10.1016\/j.vaccine.2012.05.091","article-title":"Therapy of human papillomavirus-related disease","volume":"30","author":"Stern","year":"2012","journal-title":"Vaccine"},{"key":"ref_233","first-page":"e14621","article-title":"Topical treatment for plantar warts: A systematic review","volume":"34","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-4632.2004.02318.x","article-title":"Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis","volume":"44","author":"Majewski","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1080\/21645515.2018.1445947","article-title":"Genital warts treatment: Beyond imiquimod","volume":"14","author":"Yuan","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Herzum, A., Ciccarese, G., Occella, C., Gariazzo, L., Pastorino, C., Trave, I., and Viglizzo, G. (2023). Treatment of pediatric anogenital warts in the era of HPV-vaccine: A literature review. J. Clin. Med., 12.","DOI":"10.3390\/jcm12134230"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Miyoshi, N., Tanabe, H., Suzuki, T., Saeki, K., and Hara, Y. (2020). Applications of a standardized green tea catechin preparation for viral warts and human papilloma virus-related and unrelated cancers. Molecules, 25.","DOI":"10.3390\/molecules25112588"},{"key":"ref_238","first-page":"20499361231165862","article-title":"Intralesional cidofovir for the management of refractory cutaneous verrucae: A review of applications and opportunities","volume":"10","author":"Lau","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/jocd.14737","article-title":"Comparative study between intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts","volume":"21","author":"Eldahshan","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/jocd.13712","article-title":"Efficacy and safety of intralesional injection of vitamin D3 versus tuberculin PPD in the treatment of plantar warts: A comparative controlled study","volume":"20","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1080\/07391102.2022.2091659","article-title":"In-silico discovery of inhibitors against human papillomavirus E1 protein","volume":"41","author":"Gunasinghe","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"103675","DOI":"10.1016\/j.critrevonc.2022.103675","article-title":"Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies","volume":"174","author":"Bhattacharjee","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Toots, M., Ustav, M., M\u00e4nnik, A., Mumm, K., T\u00e4mm, K., Tamm, T., Ustav, E., and Ustav, M. (2017). Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006168"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Zheng, K., Egawa, N., Shiraz, A., Katakuse, M., Okamura, M., Griffin, H.M., and Doorbar, J. (2022). The reservoir of persistent human papillomavirus infection; strategies for elimination using anti-viral therapies. Viruses, 14.","DOI":"10.3390\/v14020214"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.antiviral.2018.08.005","article-title":"Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5","volume":"158","author":"Wetherill","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"216331","DOI":"10.1016\/j.canlet.2023.216331","article-title":"A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells","volume":"571","author":"Bertagnin","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Hua, C., Zhu, Y., Wu, C., Si, L., Wang, Q., Sui, L., and Jiang, S. (2019). The underlying mechanism of 3-hydroxyphthalic anhydride-modified bovine beta-lactoglobulin to block human papillomavirus entry into the host cell. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02188"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Valencia-Res\u00e9ndiz, D.G., Villegas, A., Bahena, D., Palomino, K., Cornejo-Bravo, J.M., Quintanar, L., Palomino-Vizcaino, G., and Alvarez-Salas, L.M. (2022). Non-functionalized gold nanoparticles inhibit human papillomavirus (HPV) infection. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147552"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1073\/pnas.1917748117","article-title":"Cell-penetrating peptide inhibits retromer-mediated human papillomavirus trafficking during virus entry","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"e0151321","DOI":"10.1128\/AAC.01513-21","article-title":"Protamine sulfate is a potent inhibitor of human papillomavirus infection in vitro and in vivo","volume":"66","author":"Young","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jiph.2023.06.016","article-title":"Natural and synthetic drugs and formulations for intravaginal HPV clearance","volume":"16","author":"Khamjan","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Nadile, M., Retsidou, M.I., Gioti, K., Beloukas, A., and Tsiani, E. (2022). Resveratrol against cervical cancer: Evidence from in vitro and in vivo studies. Nutrients, 14.","DOI":"10.3390\/nu14245273"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/14\/7616\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:15:07Z","timestamp":1760109307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/14\/7616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":252,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["ijms25147616"],"URL":"https:\/\/doi.org\/10.3390\/ijms25147616","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]}}}